GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 5 6 6

+8 more TTM periods

ROE
2.52% 3.22% 4.54% 4.90%
ROA
0.89% 1.24% 2.18% 2.37%
ROIC
5.59% 5.59% 6.49% 6.35%
Return on Tangible Assets
3.59% 4.91% 7.44% 8.04%
Average Days of Receivables
84.66 107.81 107.98 92.88
Free Cash Flow per Share
0.39 0.28 0.26 0.30
Free Cash Flow
131.70 96.54 93.88 104.93
Other line items

Show all line items

Columns are period end dates